PAH: An Under-Recognized Complication of Adult-Onset Still's Disease

January 11, 2019 This article originally appeared here. Share this content: PAH is an under-diagnosed complication of adult-onset Still disease. Pulmonary arterial hypertension (PAH) is a complication of adult-onset Still disease (AOSD) that in recent years has been recognized more frequently, indicating it is more common than originally documented, according to a retrospective study published… Read More »

This Guy Got Sober, Had a 40-Pound Weight Loss Transformation, and Changed His Life

Bryant Mettler, 46, turned around a drinking problem, dropped more than 40 pounds, and changed his life. Here, Mettler—who is now sober—shares his incredible transformation story. I played soccer and basketball in high school, but I gave up organized sports in college, after my now-wife and I had a daughter at the age of 19.… Read More »

KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of Apadaz (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)

Print this page CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for two additional strengths of Apadaz, an immediate release (IR)… Read More »